[NBIX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
04-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 290.41%
YoY- -56.70%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 412,000 387,900 378,200 310,600 312,000 296,000 288,900 26.61%
PBT 117,900 97,900 -23,300 21,400 -13,800 30,500 57,500 61.18%
Tax 28,900 29,400 -6,400 7,500 -6,500 8,000 15,200 53.29%
NP 89,000 68,500 -16,900 13,900 -7,300 22,500 42,300 63.97%
Tax Rate -24.51% -30.03% - -35.05% - -26.23% -26.43% -
Total Cost 323,000 319,400 395,100 296,700 319,300 273,500 246,600 19.65%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 21.60 17.66 -4.47 4.48 -2.34 7.60 14.64 29.50%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS 0.92 0.72 -0.18 0.15 -0.08 0.24 0.45 60.87%
EPS Diluted 0.88 0.69 -0.18 0.14 -0.08 0.23 0.43 60.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.